Skip to main content
. 2022 Jun 10;11(12):3327. doi: 10.3390/jcm11123327

Table 2.

Baseline and outcome characteristics of COVID-19 patients from DATA SAVE LIVES categorized by cluster.

Stratified by Cluster
A B C p
n 496 403 147
Age 66.1 (15.8) 66.1 (13.7) 83.1 (9.9) <0.001
Sex (male (%)) 252 (50.8) 287 (71.2) 92 (62.6) <0.001
Hospitalization (days) 7.6 (5.6) 13.7 (11.9) 10.1 (7.9) <0.001
ICU stay (yes (%)) 0.10 (1.57) 1.36 (5.08) 0.17 (1.51) <0.001
Mechanical ventilation (yes (%)) 258 (52.0) 287 (71.2) 112 (76.2) <0.001
Cause of discharge (%) <0.001
 Voluntary discharge 0 (0.0) 1 (0.2) 0 (0.0)
 Home 433 (87.3) 313 (77.7) 75 (51.0)
 Death 8 (1.6) 58 (14.4) 55 (37.4)
 Health center transfer 18 (3.6) 3 (0.7) 10 (6.8)
 Hospital transfer 14 (2.8) 16 (4.0) 3 (2.0)
 Not registered 23 (4.6) 12 (3.0) 4 (2.7)
CCI 3.2 (2.4) 3.1 (2.2) 6.2 (2.2) <0.001
Myocardial infarction (yes (%)) 40 (8.1) 17 (4.3) 22 (15.1) <0.001
Congestive heart failure (yes (%)) 19 (3.8) 11 (2.8) 24 (16.4) <0.001
Peripheral vascular disease (yes (%)) 18 (3.6) 3 (0.8) 11 (7.5) <0.001
Cerebrovascular accident (yes (%)) 8 (1.6) 5 (1.3) 9 (6.2) 0.001
Dementia (yes (%)) 23 (4.6) 8 (2.0) 11 (7.5) 0.01
COPD (yes (%)) 67 (13.5) 35 (8.8) 29 (19.9) 0.002
Connective tissue disease (yes (%)) 8 (1.6) 1 (0.3) 4 (2.7) 0.041
Peptic ulcer disease (yes (%)) 1 (0.2) 0 (0.0) 1 (0.7) 0.271
Liver disease (yes (%)) 17 (3.4) 16 (4.0) 2 (1.4) 0.314
Diabetes mellitus (yes (%)) 89 (18.0) 59 (14.8) 46 (31.5) <0.001
Hemiplegia (yes (%)) 1 (0.2) 1 (0.3) 0 (0.0) 0.837
Moderate to severe CKD (yes (%)) 44 (8.9) 46 (11.6) 63 (43.2) <0.001
Solid tumor (yes (%)) 12 (2.4) 15 (3.8) 17 (11.6) <0.001
Lymphoma (yes (%)) 8 (1.6) 5 (1.3) 3 (2.1) 0.784
Leukemia (yes (%)) 4 (0.8) 2 (0.5) 2 (1.4) 0.586
AIDS (yes (%)) 0 (0.0) 2 (0.5) 0 (0.0) 0.199

p-value: ANOVA for continuous variables and chi-square for categorical variables. ICU: intensive care unit; CCI: Charlson comorbidity index; COPD: chronic obstructive pulmonary disease; CKD: chronic kidney disease; AIDS: acquired immune deficiency syndrome.